MARIO OLIVER GODOY: Open Payments
NPI 1275822611 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,615 in 84 payments from 9 companies in 2025. Trend: 2023 $620 · 2024 $1,173 · 2025 $1,615
Food & beverage: $1,615
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 16 | $443 |
| AstraZeneca Pharmaceuticals LP | 13 | $403 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 25 | $257 |
| Lilly USA, LLC | 8 | $211 |
| Exact Sciences Corporation | 14 | $157 |
| Novo Nordisk Inc | 3 | $56 |
| Amgen Inc. | 2 | $34 |
| Astellas Pharma US Inc | 2 | $29 |
| PFIZER INC. | 1 | $24 |
Products named: Kerendia, XIFAXAN, AIRSUPRA, FARXIGA, Cologuard Collection Kit, ZEPBOUND, MOUNJARO, Ozempic.
Industry payments across NV — which companies pay providers there.
